Interactive Tool to Determine Triage Category and Myeloid Cytokine Use
after a Nuclear Detonation
— Based on the Scarce Resources Project Publications
- About this interactive tool:
- Video: How to use this interactive tool?
- Full details: When and how to use this tool
- When to use: When resource availability is constrained
- Where to use: Wherever triage is performed
- Caveats: This tool does not use standard triage categories
- Disclaimer: Scarce Resources Triage Tool Disclaimer
- Source of Data: Nuclear Detonation Scarce Resources Project Working Group Publications
Step 1 of 4: Injury type
What type of injury does this patient have?
* Radiation cases include guidance on use of myeloid cytokines
Step 2 of 4: Injury severity
Do the burns cover >20% body surface area (BSA)?
Step 3 of 4: Resource availability
What is the availability of medical resources?
Step 4 of 4: Triage category and cytokine recommendations
Based on Nuclear Detonation Scarce Resources Working Group publications from March, 2011Triage category:
Minimal
Delayed
Immediate
Expectant
Expectant
Immediate
The red/black split triage category for >10 Gy indicates that some victims may receive aggressive treatment at discretion of physician, especially if 10 Gy is received over prolonged time period.
Minimal B
Minimal A
Minimal B: Consider repeating both biodosimetry and clinical assessments, especially at high end of this dose range (0.5 - 2 Gy).
Minimal A: Those with physical dose estimates based on location below 0.5 Gy need not report for medical evaluation. Joining a registry may be suggested after the incident.
Cytokine recommendation:
Category 1: Cytokine indicated.
Category 2: Cytokine indicated, lower priority than Category 1.
Category 3: Cytokine not indicated.
Expectant - Category 3: Cytokine not indicated.
Immediate - Category 2: Cytokine indicated, lower priority than Category 1.
See also:
- Download triage tool for use offline by downloading REMM
- Download Mobile REMM which includes this triage tool
- Print triage tool cards (PDF - 664 KB)
- See REMM information about myeloid cytokines